Dr. Vincenzo Di Marzo is a Research Director at the Institute of Biomolecular Chemistry of the National Research Council (ICB-CNR) in Pozzuoli, Naples, Italy, coordinator of the Endocannabinoid Research Group in the Naples region, and an Adjunct Associate Professor in the Department of Pharmacology and Toxicology at the Medical College of Virginia at Virginia Commonwealth University in Richmond. He was appointed Honorary Professor at Buckingham University, UK, in December 2012. He has qualified as Full Professor in Pharmacology in January 2014. He is Director of ICB-CNR since June 2014.

Dr. Di Marzo was awarded a ChemD from the University of Naples in 1983, and a PhD in Biochemistry and molecular pharmacology from Imperial College in London in 1988. He also completed postdoctoral studies in lipid biochemistry and natural product chemistry at ICB-CNR in 1990.
Dr. Di Marzo is co-author of more than 590 articles published in peer-reviewed journals, including several reviews on endocannabinoids. In addition, he is, or has been, on the editorial board of Prostaglandins, Leukotrienes, and Essential Fatty Acids; Critical Reviews in Neurobiology; Recent Patents in CNS Drug Discovery; CNS & Neurological Disorders-Drug Targets; The Open Medicinal Chemistry Journal; Lipids in Health and Disease; The Open Drug Discovery Journal; The British Journal of Pharmacology. He is Editor-in-Chief of Recent Patents on CNS Drug Discovery.